Published in Neurosci Biobehav Rev on January 01, 1993
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct (2008) 6.32
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry (2006) 2.68
Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron (2012) 1.81
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci (2010) 1.71
Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum. Int J Neuropsychopharmacol (2010) 1.46
The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice. Psychopharmacology (Berl) (2006) 1.45
Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci (2007) 1.45
Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology (Berl) (2010) 1.31
Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior. Proc Natl Acad Sci U S A (2013) 1.26
Electrical stimulation of the lateral habenula produces enduring inhibitory effect on cocaine seeking behavior. Neuropharmacology (2010) 1.19
Neuropeptide expression in rats exposed to chronic mild stresses. Psychopharmacology (Berl) (2004) 1.02
Stress-related alterations of visceral sensation: animal models for irritable bowel syndrome study. J Neurogastroenterol Motil (2011) 1.00
The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J Biomed Biotechnol (2011) 0.97
Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the Flinders Sensitive Line rat: a genetic rodent model of depression. Neuropsychopharmacology (2011) 0.97
Blunted accumbal dopamine response to cocaine following chronic social stress in female rats: exploring a link between depression and drug abuse. Psychopharmacology (Berl) (2011) 0.97
Biological basis for the co-morbidity between smoking and mood disorders. J Dual Diagn (2009) 0.96
Molecules and circuits involved in nicotine addiction: The many faces of smoking. Neuropharmacology (2013) 0.94
Bipolar disorder: candidate drug targets. Mt Sinai J Med (2008) 0.90
A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test. Psychopharmacology (Berl) (2005) 0.90
Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours. PLoS One (2010) 0.90
Mind the gap: glucocorticoids modulate hippocampal glutamate tone underlying individual differences in stress susceptibility. Mol Psychiatry (2014) 0.89
Fear induced neuronal alterations in a genetic model of depression: an fMRI study on awake animals. Neurosci Lett (2010) 0.87
Changes in the cholinergic system between bipolar depression and euthymia as measured with [123I]5IA single photon emission computed tomography. Biol Psychiatry (2013) 0.86
Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders. Br J Pharmacol (2016) 0.86
Traumatic brain injury - modeling neuropsychiatric symptoms in rodents. Front Neurol (2013) 0.86
The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited. Eur J Pharmacol (2014) 0.86
Acute citalopram has different effects on regional 5-HT synthesis in FSL, FRL, and SDP rats: an autoradiographic evaluation. Brain Res Bull (2008) 0.83
Nerve growth factor (NGF) has novel antidepressant-like properties in rats. Pharmacol Biochem Behav (2009) 0.83
Potential therapeutic uses of mecamylamine and its stereoisomers. Pharmacol Biochem Behav (2013) 0.82
Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression. Brain Res Bull (2008) 0.81
Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression. Pharmacol Biochem Behav (2012) 0.81
The reward system and maternal behavior in an animal model of depression: a microdialysis study. Psychopharmacology (Berl) (2007) 0.81
Effects of antidepressants on the performance in the forced swim test of two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions. Psychopharmacology (Berl) (2010) 0.80
Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test. Behav Brain Res (2015) 0.80
Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression-An Animal Model Study. Adv Pharmacol Sci (2009) 0.80
Autism-related behavioral phenotypes in an inbred rat substrain. Behav Brain Res (2014) 0.80
A prescription to resist proscriptions for murine models of depression. Psychopharmacology (Berl) (2001) 0.79
Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum rat. Psychopharmacology (Berl) (2010) 0.79
Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence. Nicotine Tob Res (2015) 0.79
Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats. Psychopharmacology (Berl) (2010) 0.79
Altered explorative strategies and reactive coping style in the FSL rat model of depression. Front Behav Neurosci (2015) 0.78
Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments. Depress Anxiety (2011) 0.77
S-Ketamine Rapidly Reverses Synaptic and Vascular Deficits of Hippocampus in Genetic Animal Model of Depression. Int J Neuropsychopharmacol (2016) 0.77
Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features. Psychopharmacology (Berl) (2015) 0.77
Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties. Psychopharmacology (Berl) (2005) 0.76
The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders:A Potential Noveltreatment? Curr Neuropharmacol (2015) 0.76
Neuromodulation, Emotional Feelings and Affective Disorders. Mens Sana Monogr (2016) 0.75
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates. Curr Neuropharmacol (2015) 0.75
Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression. Psychopharmacology (Berl) (2004) 0.75
ZL006, a small molecule inhibitor of PSD-95/nNOS interaction, does not induce antidepressant-like effects in two genetically predisposed rat models of depression and control animals. PLoS One (2017) 0.75